ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0049

IL-18 Receptor-α Signaling Pathway Contributes to Autoantibody-induced Arthritis via Neutrophil Recruitment

Shinjiro Kaieda and Tomoaki Hoshino, Kurume University School of Medicine, Kurume, Japan

Meeting: ACR Convergence 2022

Keywords: Animal Model, innate immunity, neutrophils, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: RA – Animal Models Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: We have previously reported that IL-18 levels in the lungs, serum and bronchoalveolar lavage fluid (BALF) were increased in patients with idiopathic pulmonary lung fibrosis (Am J Respir Cell Mol Biol. 2004;31:619-625). Furthermore, we have demonstrated critical roles of IL-18 in the mouse acute lung injury which is resulting in death from interstitial pneumonia induced by administration of IL-18 plus IL-2 and bleomycin-induced lung fibrosis model (Blood. 2002;99:1289-9, Am J Respir Cell Mol Biol. 2009;41:661-70). Reduced neutrophil accumulation in the lung tissues obtained from bleomycin-treated IL-18 receptor-α (IL-18R α)- and IL-18-deficient mice was observed (Blood. 2002; 99:1289-9). We have also reported that IL-18 receptor complex could be serum biomarker of RA and these evidence clearly indicate the involvement of IL-18 and its receptor system in inflammatory arthritis (Arthritis Res Ther. 2011;13:R52). However, it remains unclear how the IL-18/IL-18Rα signaling pathway functions in the autoimmune inflammatory arthritis. This study investigated the contribution of IL-18/IL-18Rα signaling in autoantibody-induced arthritis.

Methods: C57BL/6 IL-18Rα gene deficient (-/-) mice were used in K/BxN serum transfer arthritis. Synovial tissue resident neutrophils were identified myeloperoxidase-positive cells by immunohistochemistry. Murine fibroblast-like synoviocytes (FLS) were stimulated with recombinant mouse IL-1β or IL-18. mRNA levels of IL-18, CXCL1, IL-8 and IL-1β were analyzed in cultured cells. Synovial tissue expression of IL-18, IL-1β and CXCL1 mRNA was also investigated by RT-PCR.

Results: IL-18 mRNA expression exhibited significant upregulation in mouse inflamed synovial tissue during K/BxN serum transfer arthritis (Fig1a). Consistent with in vivo data, mouse FLS can produce IL-18 mRNA after stimulation with recombinant IL-1β (Fig 1b).

In IL-18Rα-/- mouse, we observed a less disease severity that was accompanied by lower IL-1β gene expression in the joints as compared to WT control mice (Fig2a and d). Histomorphometric quantification of the arthritic changes in the joint tissues confirmed the clinical assessment, with significant decreases in histopathological scores in IL-18Rα−/− (Fig. 2b and c). Infiltration of neutrophils in the arthritic synovium was significantly reduced in IL-18Rα−/−mice compared to that of WT B6 mice. IL-18 has been reported to induce CXC chemokines by synovial fibroblasts in rheumatoid arthritis (Figure3 a and b). We examined the expression of neutrophil chemotaxis CXCL1 in the mouse ankle tissues and was significantly reduced in the arthritic mouse ankles obtained from IL-18 Rα−/− mice (Fig3c). Stimulation of mouse FLS in vitro with recombinant mouse IL-18 resulted in increased expression of CXCL1 (Figure3d). These results suggested the potential contribution of IL-18 to neutrophil recruitment via inducing chemokine CXCL1 from murine FLS during arthritis.

Conclusion: IL-18/IL-18Rα signaling contributes to autoantibody-induced arthritis via inducing neutrophil recruitment. Inhibition of IL-18/IL-18Rα signaling could be an attractive therapeutic potential target in RA.

Supporting image 1

To determine whether K/BxN serum transfer arthritis stimulates IL_18 expression, we measured the mRNA expression of IL_18 in the synovium of WT B6 mice before or 8 days after injection of K/BxN serum by RT-PCR. IL_18 mRNA was significantly increased in mouse joints during K/BxN serum transfer arthritis (Fig. 1a). Consistent with in vivo data, mouse FLS can produce IL_18 mRNA after stimulation with recombinant IL_1β (Fig 1b).

Supporting image 2

To explore the role of IL_18 signaling in RA mouse model, we induced K/BxN serum transfer arthritis in female B6 mice lacking the IL_18Rα. We found that IL_18 Rα−/− mice exhibited significantly lower arthritis clinical scores and ankle thickness throughout the disease course, when compared with control WT B6 mice (Fig. 2a). Histomorphometric quantification of the arthritic changes in the joint tissues confirmed the clinical assessment, with significant decreases in histopathological scores in IL_18Rα−/− (Fig. 2b). Figure2c provides representative images of inflammatory cell infiltration, synovitis and bone destruction in the ankle tissues in IL_18Rα−/− mice (right) compared to control B6 WT mice (left). mRNA expression of IL_1β was downregulated significantly in the ankle joints obtained from IL_18Rα−/− mice as compared to control mice (Fig. 2d)

Supporting image 3

Neutrophils play critical roles for the development of K/BxN serum transfer arthritis. Neutrophils from RA synovial fluids express IL_18Rα and promote neutrophil adhesion and migration, inflammatory cytokine and chemokine production via IL_18 stimulation. Since we have previously reported that reduced neutrophil accumulation in the lung tissues obtained from bleomycin-treated IL_18Rα−/− mice, we have sought to whether IL_18/IL_18R signaling contributes to neutrophil infiltration during K/BxN serum transfer arthritis. As demonstrated in Figure 3a and b, infiltration of neutrophils in the arthritic synovium was significantly reduced in IL_18Rα−/−mice compared to that of WT B6 mice. IL_18 has been reported to induce CXC chemokines by synovial fibroblasts in rheumatoid arthritis tissues . We examined the expression of neutrophil chemotaxis CXCL1 in the mouse ankle tissues and was significantly reduced in the arthritic mouse ankles obtained from IL_18 Rα−/− mice (Fig3c). To investigate whether IL_18 induces chemokine CXCL1 production in FLS, murine FLS were stimulated with or without recombinant mouse IL_18 for 24 hours. Stimulation of mouse FLS in vitro with recombinant mouse IL_18 resulted in increased expression of CXCL1 (Figure 3d).


Disclosures: S. Kaieda, None; T. Hoshino, None.

To cite this abstract in AMA style:

Kaieda S, Hoshino T. IL-18 Receptor-α Signaling Pathway Contributes to Autoantibody-induced Arthritis via Neutrophil Recruitment [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/il-18-receptor-%ce%b1-signaling-pathway-contributes-to-autoantibody-induced-arthritis-via-neutrophil-recruitment/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-18-receptor-%ce%b1-signaling-pathway-contributes-to-autoantibody-induced-arthritis-via-neutrophil-recruitment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology